34.46000 USD
1.05
3.14%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
32.75
35.15500
Previous close
33.41000
Open
33.80000
Access this stock data via API
Subscribe
Lyell Immunopharma, Inc.
34.46
1.05
3.14%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 61K 130K 84.7M 10.7M
Cost of revenue
Gross profit
Operating expense
Research & development 171.6M 182.9M 159.2M 138.7M
Selling general and admin 52.0M 67.0M 117.3M 89.1M
Other operating expenses -3.3M -2.8M -4.8M -2.3M
Operating income -220.3M -247.0M -187.1M -214.8M
Non operating interest income
Income 24.1M 23.5M 7.1M 1.2M
Expense
Other income expense -146.8M -11.1M -3.1M -36.6M
Pretax income -343.0M -234.6M -183.1M -250.2M
Tax provision
Net income -343.0M -234.6M -183.1M -250.2M
Basic EPS -23.3 -0.9 -0.7 -1.8
Diluted EPS -23.3 -0.9 -0.7 -1.8
Basic average shares 14.7M 251.0M 247.1M 135.9M
Diluted average shares 14.7M 251.0M 247.1M 135.9M
EBITDA -49.2M -213.8M -164.0M -164.7M
Net income from continuing op. -343.0M -234.6M -183.1M -250.2M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 10 hours 47 minutes

17:12
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).